摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-one

中文名称
——
中文别名
——
英文名称
1-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-one
英文别名
1-[6-amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-one
1-[6-Amino-9-methyl-8-(triazol-2-yl)purin-2-yl]butan-2-one化学式
CAS
——
化学式
C12H14N8O
mdl
——
分子量
286.29
InChiKey
YVIPZNHRQMRADV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    117
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • ADENOSINE RECEPTOR MODULATORS FOR THE TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    申请人:Oxford University Innovation Limited
    公开号:EP3280414A1
    公开(公告)日:2018-02-14
  • Adenosine Receptor Modulators for the Treatment of Circadian Rhythm Disorders
    申请人:OXFORD UNIVERSITY INNOVATION LIMITED
    公开号:US20190111069A1
    公开(公告)日:2019-04-18
    The present invention relates to the use of adenosine receptor modulators to affect the circadian rhythm, in particular, to the use of such modulators for the treatment of circadian rhythm disorders. In particular, the invention relates to a composition comprising at least one selective adenosine receptor modulator, wherein said composition modulates two or three, but not all of adenosine receptor subtypes A 1 , A 2A , A 2B and/or A 3 for use in the treatment of circadian rhythm disorders or for modulating a biological clock.
  • [EN] ADENOSINE RECEPTOR MODULATORS FOR THE TREATMENT OF CIRCADIAN RHYTHM DISORDERS<br/>[FR] MODULATEURS DU RÉCEPTEUR DE L'ADÉNOSINE DESTINÉS AU TRAITEMENT DE TROUBLES DU RYTHME CIRCADIEN
    申请人:UNIV OXFORD INNOVATION LTD
    公开号:WO2017178820A1
    公开(公告)日:2017-10-19
    The present invention relates to the use of adenosine receptor modulators to affect the circadian rhythm, in particular, to the use of such modulators for the treatment of circadian rhythm disorders. In particular, the invention relates to a com position com prising at least one selective adenosine receptor modulator, wherein said composition modulates two or three, but not al l of adenosine receptor subtypes A1, A2A, A2B and/or A3 for use in the treatment of circadian rhythm disorders or for modulating a biological clock.
查看更多